Abstract
Six patients who had surgical treatment for sclerosing peritonitis caused by practolol now have a respiratory disorder characterised by dyspnœa, extensive fibrotic pleural thickening, and lesions in the lung parenchyma. Respiratory disease appears to be a further feature of the practolol syndrome.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have